作者
Brian Walitt,Komudi Singh,Samuel R. LaMunion,Mark Hallett,Steve Jacobson,Kong Y. Chen,Yoshimi Enose‐Akahata,Richard Apps,Jennifer J. Barb,Patrick Bédard,Robert J. Brychta,Ashura Buckley,Peter D. Burbelo,Brice Calco,Brianna Cathay,Li Chen,Snigdha Chigurupati,Jinguo Chen,Foo Cheung,Lisa M. K. Chin,Benjamin W. Coleman,Amber B. Courville,Madeleine S. Deming,Bart Drinkard,Li Rebekah Feng,Luigi Ferrucci,Scott A. Gabel,Angelique Gavin,David S. Goldstein,Shahin Hassanzadeh,Sean C. Horan,Silvina G. Horovitz,Kory R. Johnson,Anita Jones Govan,Kristine M. Knutson,Joy D. Kreskow,Mark Levin,Jonathan J. Lyons,Nicholas Madian,Nasir Malik,Andrew L. Mammen,John A. McCulloch,Patrick McGurrin,Joshua D. Milner,Ruin Moaddel,Geoffrey A. Mueller,Amrita Mukherjee,Sandra Muñoz-Braceras,Gina Norato,Katherine Pak,Iago Pinal‐Fernandez,Traian Popa,Lauren Reoma,Michael N. Sack,Farinaz Safavi,Leorey N. Saligan,Brian A. Sellers,Stephen Sinclair,Bryan Smith,Joseph Snow,Stacey Solin,Barbara Stussman,Giorgio Trinchieri,Sara A. Turner,C. Stephenie Vetter,Felipe Vial,Carlotta Vizioli,Ashley Williams,Shanna Yang,Avindra Nath
摘要
Abstract Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous criteria to recruit PI-ME/CFS participants with matched controls to conduct deep phenotyping. Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. Together these clinical abnormalities and biomarker differences provide unique insight into the underlying pathophysiology of PI-ME/CFS, which may guide future intervention.